MAHWAH, N.J., Dec. 1, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today introduced the Mindray V Series patient monitoring system, an all new scalable platform that focuses on the clarity and continuity of data at a single point of care. The V Series solution is the result of research focused on identifying the unique challenges of critical care and other high acuity environments. The V Series has been conceived, tested and proven in a true environment by the end-users who understand the complexities and workflows. It addresses the need for more effective care without information overload and unnecessary alarms; it simply focuses on the most critical information. This advanced monitoring system provides the market with a unique blend of familiar parameters and a sustainable platform enabling the future expandability required by today's global healthcare institutions.
The V Series V21 and V12 patient monitoring system has the flexibility and adaptability for clinicians' changing environments and provides the users with an advanced device anywhere in their facilities. The system also provides immediate connectivity through its thread-safe VAccess application, bringing the user in touch with patient data streams, such as electronic medical records, at a single location, without compromising the monitoring of patients.
The V Series delivers a modernized user interface that is consistent, predictable and intuitive. These vital product qualities are finally being brought to the medical arena and the benefits of this innovative product will be realized by both healthcare providers as well as patients.
"The V Series was created based on our over 40 years of experience in monitoring devices and represents our most advanced patient monitoring system yet. This is the first of several new platforms we plan to introduce over the next few years that will dramatically expand our served markets in the US and worldwide. The V Series embodies our vision of creating highly differentiated products through innovations in accessibility which will enable streamlined patient care," said David Gibson, President, Mindray North America.
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.
SOURCE Mindray Medical International Limited